SIMPSON BIOTECH CO., LTD.
About
Company description
Simpson Biotech leverages a unique combination of traditional fermentation processes and modern technologies to provide solutions for health, food, and research market places.
Established in 1998 and located in Taipei, Taiwan, Simpson Biotech Co Ltd focuses on the development and commercialization of bio-fermentation of medicinal fungus as dietary supplements and the isolation of active compounds from the fungal mycelia. Simpson Biotech has developed a patented platform technology for recombinant proteins expression and purification for biosimilars and industrial enzymes.SBC has developed a cost-effective platform technology that significantly reduces the production costs of recombinant proteins, biologics, and industrial enzymes by improving their purification processes.
Taiwan's leading R&D Bio-Fermentation Company produces:
1. Fermented Antrodia cinnamomea mycelia (w/ hepatoprotective, anti-inflammative compounds patented)
2. Water soluble Chitosan (antimicrobial at 50 ppm)
3. Fermented Ginsenoside Compound-K (CK)
4. Low-molecular (~0.4Kd) hydrolyzed peptides (Soy, Collagen, Silk)
5. Enzymatic Hydrolyzed Seaweeds (Sulfated polysaccharides)
6. Recombinant Industrial enzymes.
>25 Patents issued.
Quick facts
| Sales markets | Africa; Asia; Australia; Central/South America; Eastern Europe; Middle East; North America; Western Europe |
|---|---|
| Primary business activity | Manufacturer: Ingredients / Additives |
| Affiliated categories: | Chitin-glucan |Collagen peptides |Ginseng More |
